234 related articles for article (PubMed ID: 23399652)
21. Efficacy and toxicity of intensity-modulated radiation therapy for prostate cancer in Chinese patients.
Poon DM; Chan SL; Leung CM; Lee KM; Kam MK; Yu BK; Chan AT
Hong Kong Med J; 2013 Oct; 19(5):407-15. PubMed ID: 23784530
[TBL] [Abstract][Full Text] [Related]
22. Emergence of integrated urology-radiation oncology practices in the State of Texas.
Jhaveri PM; Sun Z; Ballas L; Followill DS; Hoffman KE; Jiang J; Smith BD
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):15-9. PubMed ID: 22789491
[TBL] [Abstract][Full Text] [Related]
23. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.
Martinez AA; Demanes DJ; Galalae R; Vargas C; Bertermann H; Rodriguez R; Gustafson G; Altieri G; Gonzalez J
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1322-31. PubMed ID: 16029788
[TBL] [Abstract][Full Text] [Related]
24. Outcome and toxicity for patients treated with intensity modulated radiation therapy for localized prostate cancer.
Vora SA; Wong WW; Schild SE; Ezzell GA; Andrews PE; Ferrigni RG; Swanson SK
J Urol; 2013 Aug; 190(2):521-6. PubMed ID: 23415964
[TBL] [Abstract][Full Text] [Related]
25. Androgen deprivation therapy for asymptomatic advanced prostate cancer in the prostate specific antigen era: a national survey of urologist beliefs and practices.
Wasson JH; Fowler FJ; Barry MJ
J Urol; 1998 Jun; 159(6):1993-6; discussion 1996-7. PubMed ID: 9598505
[TBL] [Abstract][Full Text] [Related]
26. Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly.
Hollenbeck BK; Kaufman SR; Yan P; Herrel LA; Borza T; Schroeck FR; Jacobs BL; Skolarus TA; Shahinian VB
Eur Urol; 2018 Apr; 73(4):491-498. PubMed ID: 28823605
[TBL] [Abstract][Full Text] [Related]
27. Radiotherapy and surgery for high-risk localized prostate cancer: a UK questionnaire survey of urologists and clinical oncologists.
Gnanapragasam VJ; Persad R; Payne HA
BJU Int; 2012 Sep; 110(5):608-12. PubMed ID: 22765394
[No Abstract] [Full Text] [Related]
28. The effect of selection and referral biases for the treatment of localised prostate cancer with surgery or radiation.
Wallis CJD; Morton G; Herschorn S; Kodama RT; Kulkarni GS; Appu S; Shayegan B; Buckley R; Grabowski A; Narod SA; Nam RK
Br J Cancer; 2018 May; 118(10):1399-1405. PubMed ID: 29593338
[TBL] [Abstract][Full Text] [Related]
29. Association between urologist characteristics and radiation oncologist consultation for patients with locoregional prostate cancer.
Quek RG; Ward KC; Master VA; Lin CC; Portier KM; Virgo KS; Lipscomb J
J Natl Compr Canc Netw; 2015 Mar; 13(3):303-9. PubMed ID: 25736007
[TBL] [Abstract][Full Text] [Related]
30. Health Care Integration and Quality among Men with Prostate Cancer.
Herrel LA; Kaufman SR; Yan P; Miller DC; Schroeck FR; Skolarus TA; Shahinian VB; Hollenbeck BK
J Urol; 2017 Jan; 197(1):55-60. PubMed ID: 27423758
[TBL] [Abstract][Full Text] [Related]
31. Urologists' referral and radiation oncologists' treatment patterns regarding high-risk prostate cancer patients receiving radiotherapy within 6 months after radical prostatectomy: A prospective cohort analysis.
Egger S; Smith DP; Brown BB; Kneebone AB; Dominello A; Brooks AJ; Young J; Xhilaga M; Haines M; O'Connell DL
J Med Imaging Radiat Oncol; 2020 Feb; 64(1):134-143. PubMed ID: 31793211
[TBL] [Abstract][Full Text] [Related]
32. The prostate cancer treatment bazaar: comment on "Physician visits prior to treatment for clinically localized prostate cancer".
Barry MJ
Arch Intern Med; 2010 Mar; 170(5):450-2. PubMed ID: 20212181
[No Abstract] [Full Text] [Related]
33. Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer.
Kim SP; Gross CP; Nguyen PL; Smaldone MC; Thompson RH; Shah ND; Kutikov A; Han LC; Karnes RJ; Ziegenfuss JY; Tilburt JC
Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):163-9. PubMed ID: 24566445
[TBL] [Abstract][Full Text] [Related]
34. The PROCAINA (PROstate CAncer INdication Attitudes) Project (Part I): a survey among Italian radiation oncologists on postoperative radiotherapy in prostate cancer.
Alongi F; De Bari B; Franco P; Ciammella P; Chekrine T; Livi L; Jereczek-Fossa BA; Filippi AR;
Radiol Med; 2013 Jun; 118(4):660-78. PubMed ID: 23358818
[TBL] [Abstract][Full Text] [Related]
35. Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer.
Swisher-McClure S; Pollack CE; Christodouleas JP; Guzzo TJ; Haas NB; Vapiwala N; Bekelman JE
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):8-15. PubMed ID: 22079721
[TBL] [Abstract][Full Text] [Related]
36. Two Specialists, Two Recommendations: Discordance Between Urologists' & Radiation Oncologists' Prostate Cancer Treatment Recommendations.
Delaney RK; Sisco-Taylor BL; Wang X; Scherr K; Ubel PA; Haaland B; Kahn VC; Hamstra D; Wei JT; Madanay F; Davis JK; Greeno TU; Fagerlin A
Urology; 2022 Nov; 169():156-161. PubMed ID: 35768027
[TBL] [Abstract][Full Text] [Related]
37. Nodal Clearance Rate and Long-Term Efficacy of Individualized Sentinel Node-Based Pelvic Intensity Modulated Radiation Therapy for High-Risk Prostate Cancer.
Müller AC; Eckert F; Paulsen F; Zips D; Stenzl A; Schilling D; Alber M; Bares R; Martus P; Weckermann D; Belka C; Ganswindt U
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):263-71. PubMed ID: 26853335
[TBL] [Abstract][Full Text] [Related]
38. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists.
Fowler FJ; Bin L; Collins MM; Roberts RG; Oesterling JE; Wasson JH; Barry MJ
Am J Med; 1998 Jun; 104(6):526-32. PubMed ID: 9674714
[TBL] [Abstract][Full Text] [Related]
39. Does Specialty Bias Trump Evidence in the Management of High-risk Prostate Cancer?
Kishan AU; Duchesne G; Wang PC; Rwigema JM; Saigal C; Rettig M; Steinberg ML; King CR
Am J Clin Oncol; 2018 Jun; 41(6):549-557. PubMed ID: 27560157
[TBL] [Abstract][Full Text] [Related]
40. Is primary prostate cancer treatment influenced by likelihood of extraprostatic disease? A surveillance, epidemiology and end results patterns of care study.
Holmes JA; Wang AZ; Hoffman KE; Hendrix LH; Rosenman JG; Carpenter WR; Godley PA; Chen RC
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):88-94. PubMed ID: 22300560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
